Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Autologous hematopoietic stem cell transplantation for autoimmune diseases

Identifieur interne : 001725 ( PascalFrancis/Curation ); précédent : 001724; suivant : 001726

Autologous hematopoietic stem cell transplantation for autoimmune diseases

Auteurs : A. Gratwohl [Suisse] ; J. Passweg [Suisse] ; C. Bocelli-Tyndall [Suisse] ; A. Fassas [Grèce] ; J. M. Van Laar [Pays-Bas] ; D. Farge [France] ; M. Andolina [Italie] ; R. Arnold [Allemagne] ; E. Carreras [Espagne] ; J. Finke [Allemagne] ; I. Kötter [Allemagne] ; T. Kozak [République tchèque] ; I. Lisukov [Russie] ; B. Löwenberg [Pays-Bas] ; A. Marmont [Italie] ; J. Moore [Australie] ; R. Saccardi [Italie] ; J. A. Snowden [Royaume-Uni] ; F. Van Den Hoogen [Pays-Bas] ; N. M. Wulffraat [Pays-Bas] ; X. W. Zhao [République populaire de Chine] ; A. Tyndall [Suisse]

Source :

RBID : Pascal:05-0217360

Descripteurs français

English descriptors

Abstract

Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
pA  
A01 01  1    @0 0268-3369
A02 01      @0 BMTRE9
A03   1    @0 Bone marrow transplant. : (Basingstoke)
A05       @2 35
A06       @2 9
A08 01  1  ENG  @1 Autologous hematopoietic stem cell transplantation for autoimmune diseases
A11 01  1    @1 GRATWOHL (A.)
A11 02  1    @1 PASSWEG (J.)
A11 03  1    @1 BOCELLI-TYNDALL (C.)
A11 04  1    @1 FASSAS (A.)
A11 05  1    @1 VAN LAAR (J. M.)
A11 06  1    @1 FARGE (D.)
A11 07  1    @1 ANDOLINA (M.)
A11 08  1    @1 ARNOLD (R.)
A11 09  1    @1 CARRERAS (E.)
A11 10  1    @1 FINKE (J.)
A11 11  1    @1 KÖTTER (I.)
A11 12  1    @1 KOZAK (T.)
A11 13  1    @1 LISUKOV (I.)
A11 14  1    @1 LÖWENBERG (B.)
A11 15  1    @1 MARMONT (A.)
A11 16  1    @1 MOORE (J.)
A11 17  1    @1 SACCARDI (R.)
A11 18  1    @1 SNOWDEN (J. A.)
A11 19  1    @1 VAN DEN HOOGEN (F.)
A11 20  1    @1 WULFFRAAT (N. M.)
A11 21  1    @1 ZHAO (X. W.)
A11 22  1    @1 TYNDALL (A.)
A14 01      @1 University Hospital @2 Basel @3 CHE @Z 1 aut. @Z 2 aut.
A14 02      @1 Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital @2 Basel @3 CHE @Z 3 aut. @Z 22 aut.
A14 03      @1 George Papanicolaou Hospital @2 Thessaloniki @3 GRC @Z 4 aut.
A14 04      @1 Leiden University Medical Center @2 Leiden @3 NLD @Z 5 aut.
A14 05      @1 Hôpital St Louis @2 Paris @3 FRA @Z 6 aut.
A14 06      @1 Istituto per l'Infanzia Burlo Garofolo @2 Trieste @3 ITA @Z 7 aut.
A14 07      @1 Universitätsklinikum Charité @2 Berlin @3 DEU @Z 8 aut.
A14 08      @1 Hospital Clinic @2 Barcelona @3 ESP @Z 9 aut.
A14 09      @1 Klinikum der Albert-Ludwigs Universität Freiburg @2 Freiburg @3 DEU @Z 10 aut.
A14 10      @1 Medizinische Universitdtsklinik @2 Tübingen @3 DEU @Z 11 aut.
A14 11      @1 University Hospital Krulovske Vinohrady @2 Prague @3 CZE @Z 12 aut.
A14 12      @1 Institute of Clinical Immunology @2 Novosibirsk @3 RUS @Z 13 aut.
A14 13      @1 Erasmus University Medical Center @2 Rotterdam @3 NLD @Z 14 aut.
A14 14      @1 Ospedale San Martino @2 Genova @3 ITA @Z 15 aut.
A14 15      @1 St Vincents Hospital @2 Sydney @3 AUS @Z 16 aut.
A14 16      @1 Ospedale di Careggi @2 Florence @3 ITA @Z 17 aut.
A14 17      @1 Sheffield Teaching Hospitals NHS Trust @2 Sheffield @3 GBR @Z 18 aut.
A14 18      @1 University Medical Center St Radboud @2 Nijmegen @3 NLD @Z 19 aut.
A14 19      @1 University Hospital for Children @2 Utrecht @3 NLD @Z 20 aut.
A14 20      @1 The Third People Hospital of Zhengzhou @2 Zhengzhou @3 CHN @Z 21 aut.
A17 01  1    @1 Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) @3 EUR
A17 02  1    @1 Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) @3 EUR
A20       @1 869-879
A21       @1 2005
A23 01      @0 ENG
A43 01      @1 INIST @2 21176 @5 354000125987370030
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 50 ref.
A47 01  1    @0 05-0217360
A60       @1 P
A61       @0 A
A64 01  1    @0 Bone marrow transplantation : (Basingstoke)
A66 01      @0 GBR
C01 01    ENG  @0 Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
C02 01  X    @0 002B27D02
C03 01  X  FRE  @0 Autogreffe @5 01
C03 01  X  ENG  @0 Autograft @5 01
C03 01  X  SPA  @0 Autoinjerto @5 01
C03 02  X  FRE  @0 Cellule hématopoïétique @5 02
C03 02  X  ENG  @0 Hematopoietic cell @5 02
C03 02  X  SPA  @0 Célula hematopoyética @5 02
C03 03  X  FRE  @0 Cellule souche @5 03
C03 03  X  ENG  @0 Stem cell @5 03
C03 03  X  SPA  @0 Célula primitiva @5 03
C03 04  X  FRE  @0 Maladie autoimmune @5 05
C03 04  X  ENG  @0 Autoimmune disease @5 05
C03 04  X  SPA  @0 Enfermedad autoinmune @5 05
C03 05  X  FRE  @0 Immunodépression @5 06
C03 05  X  ENG  @0 Immunosuppression @5 06
C03 05  X  SPA  @0 Inmunodepresión @5 06
C03 06  X  FRE  @0 Survie @5 08
C03 06  X  ENG  @0 Survival @5 08
C03 06  X  SPA  @0 Sobrevivencia @5 08
C03 07  X  FRE  @0 Traitement @5 09
C03 07  X  ENG  @0 Treatment @5 09
C03 07  X  SPA  @0 Tratamiento @5 09
C03 08  X  FRE  @0 Hématologie @5 11
C03 08  X  ENG  @0 Hematology @5 11
C03 08  X  SPA  @0 Hematología @5 11
C07 01  X  FRE  @0 Greffe @5 37
C07 01  X  ENG  @0 Graft @5 37
C07 01  X  SPA  @0 Injerto @5 37
N21       @1 150
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:05-0217360

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Autologous hematopoietic stem cell transplantation for autoimmune diseases</title>
<author>
<name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A." last="Gratwohl">A. Gratwohl</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J." last="Passweg">J. Passweg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Bocelli Tyndall, C" sort="Bocelli Tyndall, C" uniqKey="Bocelli Tyndall C" first="C." last="Bocelli-Tyndall">C. Bocelli-Tyndall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Fassas, A" sort="Fassas, A" uniqKey="Fassas A" first="A." last="Fassas">A. Fassas</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Grèce</country>
</affiliation>
</author>
<author>
<name sortKey="Van Laar, J M" sort="Van Laar, J M" uniqKey="Van Laar J" first="J. M." last="Van Laar">J. M. Van Laar</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Farge, D" sort="Farge, D" uniqKey="Farge D" first="D." last="Farge">D. Farge</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Andolina, M" sort="Andolina, M" uniqKey="Andolina M" first="M." last="Andolina">M. Andolina</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Arnold, R" sort="Arnold, R" uniqKey="Arnold R" first="R." last="Arnold">R. Arnold</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Carreras, E" sort="Carreras, E" uniqKey="Carreras E" first="E." last="Carreras">E. Carreras</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Finke, J" sort="Finke, J" uniqKey="Finke J" first="J." last="Finke">J. Finke</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I." last="Kötter">I. Kötter</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kozak, T" sort="Kozak, T" uniqKey="Kozak T" first="T." last="Kozak">T. Kozak</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>République tchèque</country>
</affiliation>
</author>
<author>
<name sortKey="Lisukov, I" sort="Lisukov, I" uniqKey="Lisukov I" first="I." last="Lisukov">I. Lisukov</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Russie</country>
</affiliation>
</author>
<author>
<name sortKey="Lowenberg, B" sort="Lowenberg, B" uniqKey="Lowenberg B" first="B." last="Löwenberg">B. Löwenberg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="13">
<s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Marmont, A" sort="Marmont, A" uniqKey="Marmont A" first="A." last="Marmont">A. Marmont</name>
<affiliation wicri:level="1">
<inist:fA14 i1="14">
<s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Moore, J" sort="Moore, J" uniqKey="Moore J" first="J." last="Moore">J. Moore</name>
<affiliation wicri:level="1">
<inist:fA14 i1="15">
<s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Saccardi, R" sort="Saccardi, R" uniqKey="Saccardi R" first="R." last="Saccardi">R. Saccardi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Snowden, J A" sort="Snowden, J A" uniqKey="Snowden J" first="J. A." last="Snowden">J. A. Snowden</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Van Den Hoogen, F" sort="Van Den Hoogen, F" uniqKey="Van Den Hoogen F" first="F." last="Van Den Hoogen">F. Van Den Hoogen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="18">
<s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Wulffraat, N M" sort="Wulffraat, N M" uniqKey="Wulffraat N" first="N. M." last="Wulffraat">N. M. Wulffraat</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Zhao, X W" sort="Zhao, X W" uniqKey="Zhao X" first="X. W." last="Zhao">X. W. Zhao</name>
<affiliation wicri:level="1">
<inist:fA14 i1="20">
<s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Tyndall, A" sort="Tyndall, A" uniqKey="Tyndall A" first="A." last="Tyndall">A. Tyndall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0217360</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0217360 INIST</idno>
<idno type="RBID">Pascal:05-0217360</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">004978</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001725</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Autologous hematopoietic stem cell transplantation for autoimmune diseases</title>
<author>
<name sortKey="Gratwohl, A" sort="Gratwohl, A" uniqKey="Gratwohl A" first="A." last="Gratwohl">A. Gratwohl</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Passweg, J" sort="Passweg, J" uniqKey="Passweg J" first="J." last="Passweg">J. Passweg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Bocelli Tyndall, C" sort="Bocelli Tyndall, C" uniqKey="Bocelli Tyndall C" first="C." last="Bocelli-Tyndall">C. Bocelli-Tyndall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
<author>
<name sortKey="Fassas, A" sort="Fassas, A" uniqKey="Fassas A" first="A." last="Fassas">A. Fassas</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Grèce</country>
</affiliation>
</author>
<author>
<name sortKey="Van Laar, J M" sort="Van Laar, J M" uniqKey="Van Laar J" first="J. M." last="Van Laar">J. M. Van Laar</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Farge, D" sort="Farge, D" uniqKey="Farge D" first="D." last="Farge">D. Farge</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Andolina, M" sort="Andolina, M" uniqKey="Andolina M" first="M." last="Andolina">M. Andolina</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Arnold, R" sort="Arnold, R" uniqKey="Arnold R" first="R." last="Arnold">R. Arnold</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Carreras, E" sort="Carreras, E" uniqKey="Carreras E" first="E." last="Carreras">E. Carreras</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Finke, J" sort="Finke, J" uniqKey="Finke J" first="J." last="Finke">J. Finke</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kotter, I" sort="Kotter, I" uniqKey="Kotter I" first="I." last="Kötter">I. Kötter</name>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kozak, T" sort="Kozak, T" uniqKey="Kozak T" first="T." last="Kozak">T. Kozak</name>
<affiliation wicri:level="1">
<inist:fA14 i1="11">
<s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>République tchèque</country>
</affiliation>
</author>
<author>
<name sortKey="Lisukov, I" sort="Lisukov, I" uniqKey="Lisukov I" first="I." last="Lisukov">I. Lisukov</name>
<affiliation wicri:level="1">
<inist:fA14 i1="12">
<s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Russie</country>
</affiliation>
</author>
<author>
<name sortKey="Lowenberg, B" sort="Lowenberg, B" uniqKey="Lowenberg B" first="B." last="Löwenberg">B. Löwenberg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="13">
<s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Marmont, A" sort="Marmont, A" uniqKey="Marmont A" first="A." last="Marmont">A. Marmont</name>
<affiliation wicri:level="1">
<inist:fA14 i1="14">
<s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Moore, J" sort="Moore, J" uniqKey="Moore J" first="J." last="Moore">J. Moore</name>
<affiliation wicri:level="1">
<inist:fA14 i1="15">
<s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Saccardi, R" sort="Saccardi, R" uniqKey="Saccardi R" first="R." last="Saccardi">R. Saccardi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="16">
<s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author>
<name sortKey="Snowden, J A" sort="Snowden, J A" uniqKey="Snowden J" first="J. A." last="Snowden">J. A. Snowden</name>
<affiliation wicri:level="1">
<inist:fA14 i1="17">
<s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Van Den Hoogen, F" sort="Van Den Hoogen, F" uniqKey="Van Den Hoogen F" first="F." last="Van Den Hoogen">F. Van Den Hoogen</name>
<affiliation wicri:level="1">
<inist:fA14 i1="18">
<s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Wulffraat, N M" sort="Wulffraat, N M" uniqKey="Wulffraat N" first="N. M." last="Wulffraat">N. M. Wulffraat</name>
<affiliation wicri:level="1">
<inist:fA14 i1="19">
<s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</inist:fA14>
<country>Pays-Bas</country>
</affiliation>
</author>
<author>
<name sortKey="Zhao, X W" sort="Zhao, X W" uniqKey="Zhao X" first="X. W." last="Zhao">X. W. Zhao</name>
<affiliation wicri:level="1">
<inist:fA14 i1="20">
<s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author>
<name sortKey="Tyndall, A" sort="Tyndall, A" uniqKey="Tyndall A" first="A." last="Tyndall">A. Tyndall</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Bone marrow transplantation : (Basingstoke)</title>
<title level="j" type="abbreviated">Bone marrow transplant. : (Basingstoke)</title>
<idno type="ISSN">0268-3369</idno>
<imprint>
<date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Bone marrow transplantation : (Basingstoke)</title>
<title level="j" type="abbreviated">Bone marrow transplant. : (Basingstoke)</title>
<idno type="ISSN">0268-3369</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Autograft</term>
<term>Autoimmune disease</term>
<term>Hematology</term>
<term>Hematopoietic cell</term>
<term>Immunosuppression</term>
<term>Stem cell</term>
<term>Survival</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Autogreffe</term>
<term>Cellule hématopoïétique</term>
<term>Cellule souche</term>
<term>Maladie autoimmune</term>
<term>Immunodépression</term>
<term>Survie</term>
<term>Traitement</term>
<term>Hématologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Cellule souche</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0268-3369</s0>
</fA01>
<fA02 i1="01">
<s0>BMTRE9</s0>
</fA02>
<fA03 i2="1">
<s0>Bone marrow transplant. : (Basingstoke)</s0>
</fA03>
<fA05>
<s2>35</s2>
</fA05>
<fA06>
<s2>9</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Autologous hematopoietic stem cell transplantation for autoimmune diseases</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>GRATWOHL (A.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>PASSWEG (J.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>BOCELLI-TYNDALL (C.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>FASSAS (A.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>VAN LAAR (J. M.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>FARGE (D.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>ANDOLINA (M.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>ARNOLD (R.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>CARRERAS (E.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>FINKE (J.)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>KÖTTER (I.)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>KOZAK (T.)</s1>
</fA11>
<fA11 i1="13" i2="1">
<s1>LISUKOV (I.)</s1>
</fA11>
<fA11 i1="14" i2="1">
<s1>LÖWENBERG (B.)</s1>
</fA11>
<fA11 i1="15" i2="1">
<s1>MARMONT (A.)</s1>
</fA11>
<fA11 i1="16" i2="1">
<s1>MOORE (J.)</s1>
</fA11>
<fA11 i1="17" i2="1">
<s1>SACCARDI (R.)</s1>
</fA11>
<fA11 i1="18" i2="1">
<s1>SNOWDEN (J. A.)</s1>
</fA11>
<fA11 i1="19" i2="1">
<s1>VAN DEN HOOGEN (F.)</s1>
</fA11>
<fA11 i1="20" i2="1">
<s1>WULFFRAAT (N. M.)</s1>
</fA11>
<fA11 i1="21" i2="1">
<s1>ZHAO (X. W.)</s1>
</fA11>
<fA11 i1="22" i2="1">
<s1>TYNDALL (A.)</s1>
</fA11>
<fA14 i1="01">
<s1>University Hospital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Stem Cell Transplant Team, Department of Rheumatology, University Basel, Felix Platter Spital</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>3 aut.</sZ>
<sZ>22 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>George Papanicolaou Hospital</s1>
<s2>Thessaloniki</s2>
<s3>GRC</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Leiden University Medical Center</s1>
<s2>Leiden</s2>
<s3>NLD</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Hôpital St Louis</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Istituto per l'Infanzia Burlo Garofolo</s1>
<s2>Trieste</s2>
<s3>ITA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Universitätsklinikum Charité</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>Hospital Clinic</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Klinikum der Albert-Ludwigs Universität Freiburg</s1>
<s2>Freiburg</s2>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Medizinische Universitdtsklinik</s1>
<s2>Tübingen</s2>
<s3>DEU</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="11">
<s1>University Hospital Krulovske Vinohrady</s1>
<s2>Prague</s2>
<s3>CZE</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="12">
<s1>Institute of Clinical Immunology</s1>
<s2>Novosibirsk</s2>
<s3>RUS</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="13">
<s1>Erasmus University Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA14 i1="14">
<s1>Ospedale San Martino</s1>
<s2>Genova</s2>
<s3>ITA</s3>
<sZ>15 aut.</sZ>
</fA14>
<fA14 i1="15">
<s1>St Vincents Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>16 aut.</sZ>
</fA14>
<fA14 i1="16">
<s1>Ospedale di Careggi</s1>
<s2>Florence</s2>
<s3>ITA</s3>
<sZ>17 aut.</sZ>
</fA14>
<fA14 i1="17">
<s1>Sheffield Teaching Hospitals NHS Trust</s1>
<s2>Sheffield</s2>
<s3>GBR</s3>
<sZ>18 aut.</sZ>
</fA14>
<fA14 i1="18">
<s1>University Medical Center St Radboud</s1>
<s2>Nijmegen</s2>
<s3>NLD</s3>
<sZ>19 aut.</sZ>
</fA14>
<fA14 i1="19">
<s1>University Hospital for Children</s1>
<s2>Utrecht</s2>
<s3>NLD</s3>
<sZ>20 aut.</sZ>
</fA14>
<fA14 i1="20">
<s1>The Third People Hospital of Zhengzhou</s1>
<s2>Zhengzhou</s2>
<s3>CHN</s3>
<sZ>21 aut.</sZ>
</fA14>
<fA17 i1="01" i2="1">
<s1>Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)</s1>
<s3>EUR</s3>
</fA17>
<fA17 i1="02" i2="1">
<s1>Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)</s1>
<s3>EUR</s3>
</fA17>
<fA20>
<s1>869-879</s1>
</fA20>
<fA21>
<s1>2005</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>21176</s2>
<s5>354000125987370030</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>50 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0217360</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Bone marrow transplantation : (Basingstoke)</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Experimental data and early phase I/II studies suggest that high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT) can arrest progression of severe autoimmune diseases. We have evaluated the toxicity and disease response in 473 patients with severe autoimmune disease treated with autologous HSCT between 1995 and 2003, from 110 centers participating in the European Group for Blood and Marrow Transplantation (EBMT) autoimmune disease working party database. Survival, transplant-related mortality, treatment response and disease progression were assessed. In all, 420 patients (89%; 86±4% at 3 years, median follow-up 20 months) were alive, 53 (11%) had died from transplant-related mortality (N=31; 7±3% at 3 years) or disease progression (N= 22; 9±4% at 3 years). Of 370 patients, 299 evaluable for response (81%) showed a treatment response, which was sustained in 213 (71% of responders). Response was associated with disease (P<0.001), was better in patients who received cyclophosphamide during mobilization (relative risk (RR)3.28 (1.57-6.83)) and was worse with increasing age (>40 years, RR0.29 (0.11-0.82)). Disease progression was associated with disease (P<0.001) and conditioning intensity (high intensity, RR1; intermediate intensity, RR1.81 (0.96-3.42)); low intensity, RR2.34 (1.074-5.11)). These data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B27D02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Autogreffe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Autograft</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Autoinjerto</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Cellule hématopoïétique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Hematopoietic cell</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Célula hematopoyética</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Cellule souche</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Stem cell</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Célula primitiva</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Maladie autoimmune</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Autoimmune disease</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Enfermedad autoinmune</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Immunodépression</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Immunosuppression</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Inmunodepresión</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Survie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Survival</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Sobrevivencia</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Hématologie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Hematology</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Hematología</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Greffe</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Graft</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Injerto</s0>
<s5>37</s5>
</fC07>
<fN21>
<s1>150</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001725 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001725 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:05-0217360
   |texte=   Autologous hematopoietic stem cell transplantation for autoimmune diseases
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024